Balchem Corporation logo

Balchem Corporation(BCPC)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
1-STAR RATING
Consider higher Upturn Star rating
BUY for 16 days
PROFIT SINCE LAST BUY
-2.18% ▼
LAST CLOSE
$173.14
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for BCPC

11/13/2026: BCPC (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Balchem Corporation is a specialty performance ingredient and chemical manufacturer operating across human nutrition, animal health, and industrial sterilization markets. The company's primary strengths lie in its proprietary microencapsulation technologies, sticky customer relationships, and consistently high operating margins. A key growth catalyst is the expanding global demand for functional foods, dietary supplements, and advanced nutritional additives. However, risks include elevated valuation multiples, sensitivity to agricultural cycles, and competition from larger chemical enterprises. The stock suits long-term growth and dividend-growth investors seeking quality defensive exposure, with monitoring required on valuation levels and raw material cost trends.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitBalchem delivers steady mid-single-digit organic growth supplemented by targeted M&A rather than explosive hyper-growth.
Momentum investorStrong fit while signal remains positiveMomentum appeal depends on positive technical breakout signals and near-term earnings beats.
Value investorMixed fitValuation multiples often command a premium due to high quality and consistent margins, limiting deep-value appeal.
Dividend investorStrong fitThe company has an extensive history of consecutive annual dividend increases backed by pristine cash flows.
Low-risk investorStrong fitLow leverage, robust balance sheet health, and defensive end-markets provide a relatively lower-risk equity profile.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMediumThe stock experiences standard equity market fluctuations but generally exhibits lower beta than cyclical chemical peers.
Valuation riskMedium / highTrading at elevated price-to-earnings multiples leaves little room for operational disappointments.
Competition risk (Specialty ingredient and flavor competition)MediumCompetition from larger global ingredient giants can pressure pricing power in core segments.
Business qualityStrongProprietary technology and sticky customer relationships underpin high franchise quality.
Dividend incomeLowThe dividend yield is modest, making it more suitable for dividend growth than immediate income generation.
Execution riskLow / noneManagement has a long history of successfully integrating bolt-on acquisitions and executing operational plans.

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 5.52B USD
Price to earnings Ratio 32.67
1Y Target Price 213.5
Price to earnings Ratio 32.67
1Y Target Price 213.5
Volume (30-day avg) 304.1K shares
Beta 0.85
52 Weeks Range 146.28 - 186.15
Updated Date 11/15/2026
52 Weeks Range 146.28 - 186.15
Updated Date 11/15/2026
Dividends yield (FY) 0.56%
Basic EPS (TTM) 5.3

Sector & Industry Intelligence

Sector

Basic Materials

Defensive
Sentiment
Bearish
Momentum
Momentum Steady
BUY participation
23.1%
Active BUY / eligible
9 / 39
30-Day BUY Count Change
+2
Market state
Bearish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Specialty Chemicals

BUY participation
57.1%
Active BUY / eligible
4 / 7
30-Day BUY Count Change
+1

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Flat / Range-Bound
PRICE PATH

Flat / Range-Bound

The stock price has been trading within a narrow range with minimal directional movement.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type Stock
Historic Profit -23.09%
Avg. Invested days 33
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
BCPC receives a 4-star rating, supported by solid unit economics, and solid company fundamentals. The rating is constrained by weak price momentum.

Company Fundamentals

★★★★★
BCPC has solid overall fundamentals (4 stars), with solid financial health, solid growth momentum, and solid ownership. In FY2025 versus FY2024, solid earnings growth (+20.5%) and strong cash generation (FCF margin 16.7%) are partially offset by moderate revenue growth (+8.8%), very low insider ownership of 0.59%.

Financial Health Rating

★★★★★
BCPC's financial health is supported by solid cash strength, including free-cash-flow generation (16.7% of revenue). Profitability is moderate (3 stars), which helps explain the 4-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is BCPC's strongest growth driver at +20.5% FY2025 versus FY2024 (solid, 4 stars). Revenue growth (+8.8%, moderate) and free-cash-flow growth (+18.3%, solid) are also constructive, though not equally high across every growth measure.

Ownership

★★★★★
Institutional ownership is 93.2% and approximately 99.1% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership is only 0.59%, which materially reduces the ownership score.

Top 5 Institutional Investors

BlackRock Inc 15.57%
Vanguard Portfolio Management, LLC 6.97%
Vanguard Capital Management, LLC 4.53%
State Street Corp 4.02%
Geode Capital Management, LLC 3.52%

Unit Economics (Per $1K Revenue)

★★★★★
BCPC generates approximately $357 of gross profit, $211 of operating income, and $167 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Solid margins and strong cash conversion support the rating, although capital efficiency remains moderate.

Economic Dimensions

★★★★★
Effective Tax Rate: 22.20%

Quantitative Style Profile

★★★★★
BCPC has a high-quality, liquid profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Quality TiltSmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Human Nutrition and HealthSupplies choline, minerals, vitamin K2, and customized powder/liquid ingredient systems for foods and supplements.This is the company's largest and fastest-growing profit engine driven by health-conscious consumer trends.
Animal Nutrition and HealthManufactures rumen-protected encapsulated nutrients to maximize livestock health and feeding efficiency.Revenue tracks farm-level economic returns and dairy market cycles.
Specialty ProductsProduces high-purity ethylene oxide gas used for medical device sterilization and agricultural fumigants.A smaller segment that delivers exceptionally high profit margins due to essential non-discretionary demand.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-10-23
When Before Market
Estimate 1.54
Actual 1.57

Profitability

Profit Margin 15.41%
Operating Margin (TTM) 20.7%

Management Effectiveness

Return on Assets (TTM) 8.53%
Return on Equity (TTM) 13.02%

Valuation

Trailing PE 32.67
Forward PE 29.59
Enterprise Value 5.60B
Price to Sales(TTM) 4.98
Enterprise Value 5.60B
Price to Sales(TTM) 4.98
Enterprise Value to Revenue 5.05
Enterprise Value to EBITDA 20.19
Shares Outstanding 31.88M
Shares Floating 31.59M
Shares Outstanding 31.88M
Shares Floating 31.59M
Percent Insiders 0.59
Percent Institutions 93.15

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.